Founded 2005 | ||
Parent organization Precision for Medicine, Inc. | ||
Precision Health Economics (PHE) is a healthcare consulting firm based in Los Angeles, CA. The company was founded in 2005 by three health economists: Dana Goldman and Darius Lakdawalla from the University of Southern California and Tomas Philipson from the University of Chicago.
Achievements
A 2005 paper by PHE - published in Forum for Health Economics and Policy - was the first to demonstrate that manufacturers of effective therapies capture only a small fraction of the societal benefits to be gained from new treatments, while most benefits go directly to patients. In May 2009, PHE presented a study assessing the value of new health technologies to the NICE Kennedy Commission, which provides recommendations for the development of UK reimbursement policy.